Skip to main content
Skip to footer

Signal Detection and Management in Pharmacovigilance


A hybrid approach to signal detection and management

Shubham Chaudhari

Domain Consultant, TCS ADD Platforms

Achyuth Tanay Kota

Domain Consultant, TCS ADD Platforms

Ashutosh Pachisia

Data Scientist, TCS ADD Platforms

You have these already downloaded

We have sent you a copy of the report to your email again.

All pharmaceutical products approved to be used in a marked setting have proven benefits but are also associated with adverse effects. The detection of such unknown risks is important to ensure the safety of patients. Signal detection and management in pharmacovigilance necessitates the ongoing monitoring of individual case safety reports (ICSR) to identify case reports of adverse events (AE) that are worthy for further exploration. Traditionally, signals are detected either qualitatively or quantitatively. Qualitative detection involves a deep analysis through manual assessment of the ICSR in an individual or cumulative manner, whereas the quantitative method involves statistical techniques such as disproportionality analysis.

In this white paper series, we propose a hybrid approach where the algorithm is fueled to assess a signal and manage it for effective grading based on a qualitative approach

Read More

About the authors

Shubham Chaudhari
Achyuth Tanay Kota
Ashutosh Pachisia

Related reading

Next-gen clinical trials on a digital platform

Customer Testimonial | 27 Jan 2023

Adopting a Design Thinking Approach for Risk-Based Monitoring

White Paper | 23 Dec 2022

The new age digital contract research organizations

White Paper | 23 Dec 2022

Bayer overhauls its trial planning process

White Paper | 23 Dec 2022

Transformation starts here

Learn how we can help you bring drugs to the market faster.

Talk to our experts

Find out more